Category: Patent Litigation
-
UPC’s Court of Appeal throws out Alexion’s appeals against Amgen and Samsung Bioepis over validity doubts, reveals €100M value of each dispute
The UPC’s Court of Appeal rejects Alexion’s appeals of decisions to deny preliminary injunctions against Amgen and Samsung Bioepis, where the value of the dispute was set at €100M for each case.
-
Japan’s Nippon Shinyaku vows to fight on in U.S. drug dispute against Sarepta Therapeutics, despite heavy $115 million blow
The Japanese pharma company initiated the drug patent litigation in 2021, but the case eventually boomeranged and a District of Delaware verdict last week ultimately handed Sarepta the win.
-
UPC responds to first antisuit attack on its jurisdiction with first anti-antisuit injunction against Netgear; Huawei also gets one from Munich I Regional Court
Context: Last week, the Unified Patent Court’s (UPC) Munich Local Division (LD) entered a final judgment, along with a permanent injunction, for Huawei and against Netgear (December 18, 2024 ip fray article). We subsequently explained the UPC’s FRAND (fair, reasonable and non-discriminatory licensing) reasoning (December 18, 2024 ip fray article) and reported on a trial that the Landgericht München…
-
In U.S. court filing that sheds light on UPC and German cases, Huawei claims to have been “repeatedly ghosted by Netgear”
A filing made by Huawei with a U.S. court on Friday accuses Netgear of repeatedly “ghosting” the Chinese innovator when it came to discussing licensing terms.
-
Xockets’ antitrust claims against Microsoft, Nvidia and RPX may fail, but group boycott of patent holders remains overarching concern
Xockets tries to salvage its antitrust claims against Microsoft, Nvidia and RPX over an alleged conspiracy not to license or buy its patents that it claims are essential to AI.
-
ITC judge recommends U.S. import ban on Amazon streaming devices due to violation of 4 out of 5 Nokia multimedia patents
Between Ericsson’s win over Lenovo and now Nokia’s over Amazon, U.S. trade judges have deemed 8 standard-essential patents valid and infringed this week.
-
Netgear running out of time against Huawei as next injunction could come down on January 9, patent exhaustion won’t move needle
Netgear faces the risk of another WiFi 6 SEP injunction coming down on January 9, and the exhaustion-based carve-out from the December 18 UPC injunction may be useless.
-
Chinese medical device makers settle six-year pulse oximeter litigation in the U.S.
Beijing Choice and Contec settled their patent infringement dispute for US$1 million, and the defendant has agreed not to sell its fingertip oximeters in the U.S. without signing a licensing agreement first.
-
UPC’s Munich LD contradicts EU Commission, separately faults Netgear for unsubstantiated rejection of Sisvel’s WiFi 6 pool license offer
Huawei won a multi-country WiFi 6 SEP injunction against Netgear today, and the UPC’s Munich LD has taken various patentee- and pool-friendly positions on FRAND.
-
Huawei wins Unified Patent Court injunction against Netgear over WiFi 6 in most important UPC SEP ruling to date
The Unified Patent Court’s Munich Local Division has granted Huawei a multi-country injunction against Netgear over a WiFi 6 standard-essential patent.